SEC. 2. REQUIRING THE REVIEW OF QUALITY MEASURES 
RELATING TO OPIOIDS AND OPIOID USE DIS-
ORDER 
TREATMENTS 
FURNISHED 
UNDER 
THE MEDICARE PROGRAM AND OTHER FED-
ERAL HEALTH CARE PROGRAMS. 
(a) IN GENERAL.—Section 1890A of the Social Secu-
rity Act (42 U.S.C. 1395aaa–1) is amended by adding at 
the end the following new subsection: 
‘‘(g) TECHNICAL EXPERT PANEL REVIEW OF OPIOID 
AND OPIOID USE DISORDER QUALITY MEASURES.— 
‘‘(1) IN GENERAL.—Not later than 180 days 
after the date of the enactment of this subsection, 
the Secretary shall establish a technical expert panel 
for purposes of reviewing quality measures relating 
to opioids and opioid use disorders, including care, 
prevention, diagnosis, health outcomes, and treat-
ment furnished to individuals with opioid use dis-
orders. The Secretary may elect to establish such 
panel through a contract with the consensus-based 
entity with a contract in effect under section 1890. 
‘‘(2) REVIEW
AND
ASSESSMENT.—Not later 
than 1 year after the date the technical expert panel 
described in paragraph (1) is established (and peri-
odically thereafter as the Secretary determines ap-
propriate), the technical expert panel shall— 
VerDate Sep 11 2014 
21:43 May 30, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5779.IH
H5779
sradovich on DSK3GMQ082PROD with BILLS
‘‘(A) review quality measures that relate to 
opioids and opioid use disorders, including ex-
isting measures and those under development; 
‘‘(B) identify gaps in areas of quality 
measurement that relate to opioids and opioid 
use disorders, and identify measure develop-
ment priorities for such measure gaps; and 
‘‘(C) make recommendations to the Sec-
retary on quality measures with respect to 
opioids and opioid use disorders for purposes of 
improving care, prevention, diagnosis, health 
outcomes, 
and 
treatment, 
including 
rec-
ommendations for revisions of such measures, 
need for development of new measures, and rec-
ommendations for including such measures in 
quality reporting programs, value-based pur-
chasing programs, accountable care organiza-
tions, and alternative payment models under 
this title. 
‘‘(3) CONSIDERATION OF MEASURES BY SEC-
RETARY.—The Secretary shall consider— 
‘‘(A) using opioid and opioid use disorder 
measures (including measures used under the 
Merit-Based Incentive Payment System under 
section 1848(q), measures recommended under 
VerDate Sep 11 2014 
21:43 May 30, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5779.IH
H5779
sradovich on DSK3GMQ082PROD with BILLS
paragraph (2)(C), and other such measures 
identified by the Secretary) in Alternative Pay-
ment Models under section 1833(z)(3)(C) and 
in the Shared Savings Program under section 
1899; and 
‘‘(B) using opioid measures described in 
subparagraph (A), as applicable, in the Hos-
pital Inpatient Quality Reporting program 
under section 1886(b)(3)(B)(viii), in the hos-
pital value-based purchasing program under 
section 1886(o), and under other value-based 
purchasing programs under this title. 
‘‘(4) PRIORITIZATION OF MEASURE DEVELOP-
MENT.—The Secretary shall prioritize for measure 
development the gaps in quality measures identified 
under paragraph (2)(C).’’. 
(b) EXPEDITED
ENDORSEMENT
PROCESS
FOR 
OPIOID MEASURES.—Section 1890(b)(2) of the Social Se-
curity Act (42 U.S.C. 1395aaa(b)(2)) is amended by add-
ing at the end the following new flush sentence: 
‘‘Such endorsement process shall, as determined 
practicable by the entity, provide for an expedited 
process with respect to the endorsement of measures 
relating to opioids and opioid use disorders.’’. 
Æ 
VerDate Sep 11 2014 
21:43 May 30, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H5779.IH
H5779
sradovich on DSK3GMQ082PROD with BILLS